To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
Seven and a half million people in the United States suffer from type 1 diabetes and depend on insulin to survive. But in the last five years, the cost of the life-saving drug in the U.S. has doubled reaching prices up to $300 a vial.
Some 40 Americans are traveling to Canada this weekend but not for recreation or pleasure.
The mechanisms of pharmaceutical rebates in Medicare Part D and commercial insurance.
Recent pharmaceutical innovations offer unprecedented possibilities for curing, treating, or preventing a range of diseases. However, patients, providers and payers alike have raised concerns about the affordability and sustainability of these drugs.